Close Menu

cancer sequencing

CHICAGO (GenomeWeb) – Research presented at the annual meeting of the American Society of Clinical Oncology this week included a wealth of data from programs using next-generation sequencing to guide treatment for cancer patients.

NEW YORK (GenomeWeb) — Researchers from the Vanderbilt University Medical Center have released a retrospective study showing that Foundation Medicine's FoundationOne test identified a potentially actionable mutation in the majority of the first 103 cancer patients to receive the test at the cente

Researchers from Washington University in St. Louis have published a case study on a patient who was successfully treated with a targeted therapy based on results of the university's clinical cancer sequencing.

A pilot study by the Translational Genomics Research Institute using whole-genome and whole-transcriptome sequencing to guide therapy for patients with advanced cancer has demonstrated that such an approach is clinically feasible, despite setbacks in timing and other logistics.

The Cleveland Clinic is beginning a study to assess the feasibility and clinical impact of using targeted sequencing, provided by Foundation Medicine, to guide cancer care for patients with a variety of solid tumors.

This is the first in a series of profiles of centers awarded grants this year under NHGRI's Clinical Sequencing Exploratory Research program.

The ranks of health centers utilizing next-gen sequencing in the care and treatment of cancer patients continue to swell with the recent adoption by two groups — Greenville Health System in South Carolina and the Roswell Park Cancer Institute in New York — of new targeted sequenc

Fox Chase Cancer Center has contracted genomics interpretation company N-of-One to interpret and curate results from its new targeted sequencing-based test, CancerCode45, creating reports for ordering physicians that link genomic findings with potential targeted therapies.

Through a newly created Institute for Precision Medicine, Weill Cornell Medical College and New York Presbyterian Hospital plan to begin offering targeted, individualized treatment informed by patients' genomes.

The Fox Chase Cancer Center has begun offering targeted sequencing to inform cancer treatment using an adaptation of Life Technologies' Ion Torrent AmpliSeq Cancer Panel via its CLIA-certified laboratory.

Pages

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.